Current Pharmaceutical Design
Title: Preface
Volume: 9 Issue: 7
Author(s): Maurizio Botta
Affiliation:
Export Options
About this article
Cite this article as:
Botta Maurizio, Preface, Current Pharmaceutical Design 2003; 9 (7) . https://dx.doi.org/10.2174/1381612033391522
DOI https://dx.doi.org/10.2174/1381612033391522 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Yoga may Prevent Cytokine Storm in COVID-19
Coronaviruses Internal Ribosome Entry Site Elements in Eukaryotic Genomes
Current Genomics Location of MBL-Associated Serine Proteases Binding Motifs on Human Mannan-Binding Lectin (MBL)
Protein & Peptide Letters T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions
Endocrine, Metabolic & Immune Disorders - Drug Targets HIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria
Protein & Peptide Letters Editorial [Human Methylome Variation and the Rise of Epigenetic Epidemiology]
Current Pharmacogenomics and Personalized Medicine Controlled Release of Protein from Hydrocolloid Gel Microbeads Before and After Drying
Current Drug Delivery Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
Current Neuropharmacology SUBJECT INDEX TO VOLUME 1
Current Drug Targets Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets Antifolates - Past, Present and Future
Current Medicinal Chemistry - Anti-Cancer Agents Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Current Cancer Drug Targets Mechanisms for Radioprotection by Melatonin; Can it be Used as a Radiation Countermeasure?
Current Molecular Pharmacology The Recognition of Abnormal Forms of HLA-B27 by CD4+ T Cells
Current Molecular Medicine Oncolytic Viruses: The Best is Yet to Come
Current Cancer Drug Targets Patent Selections
Recent Patents on Biotechnology Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets 25-hydroxyvitamin D Correlation with Prolactin Levels and Adenoma Size in Female Patients with Newly Diagnosed Prolactin Secreting Adenoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Liposomes as Versatile Platform for Cancer Theranostics: Therapy, Bio-imaging, and Toxicological Aspects
Current Pharmaceutical Design Synthesis and Evaluation of Transdermal Permeation, Pharmacological Activity of Bornyl NSAID Esters
Letters in Drug Design & Discovery